Tc Biopharm [Holdings] Plc ADR (TCBP)

$0.50 -1.04 (-67.53%)
Market Cap 205,000.00
Revenue (ttm) 0.00
Net Income (ttm) -7.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 5,896,400
Avg Vol 426,953
Day's Range N/A - N/A
Shares Out 410,000.00
Stochastic %K 0%
Beta 0.01
Analysts Strong Sell
Price Target $48.00

Company Profile

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwe...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 14 1433 7557
Address:
Maxim 1, 2 Parklands Way Holytown, Motherwell, United Kingdom
Kevin4540
Kevin4540 Feb. 23 at 6:15 PM
$TCBP
0 · Reply
ABnb15
ABnb15 Feb. 20 at 4:55 PM
$TCBP why this going up ??
0 · Reply
mldio
mldio Feb. 18 at 1:08 AM
$TCBP According to the annual report released in May 2025, over $40 million of shareholder capital was invested solely into IP research. Yet, in November 2025, this core asset was sold to CytoMed Therapeutics at a staggering "fire-sale" price. ​CytoMed, a micro-cap company with a market cap of only about $10 million, stated that the acquisition price was so "immaterial" to their operations that they chose to keep it undisclosed. If an acquisition is "immaterial" to a $10M company, at what absurdly low price did TCBP throw away an IP that cost shareholders $40M to develop? ​The deception goes deeper: ​June 2025: TCBP had already hired a bankruptcy firm to prepare for liquidation. ​August 2025: At the General Meeting, they pushed through value-destroying 'Deferred Shares'. ​The Lie: They told us these shares were to "flexibly raise capital to remain a going concern."that's totally BS.
0 · Reply
mldio
mldio Feb. 15 at 2:09 PM
$TCBP Under a YouTube video where Kobel gets totally knocked down, someone commented this: Apparently the CEO is a regular at a restaurant his wife runs, and he even brings that so-called “service dog” there and talks down to the staff the whole time. They say he’s pretty infamous in that area. This is who he really is.
0 · Reply
Blastus
Blastus Feb. 5 at 9:22 PM
$TCBP after a long time away, i came back to see Brian got punched in the face. Good. Dude is a sleezeball if I've ever seen one.
0 · Reply
RavsCan
RavsCan Feb. 2 at 2:41 PM
$TCBP old investor here. its a scam. dont even look in this direction. i’ve lost a ton. dont want others to follow. PLEASE LOOK AWAY.
0 · Reply
chris_stocks
chris_stocks Jan. 26 at 2:56 PM
$TCBP I hope Brian kobel dies very painfully
0 · Reply
mmtiddy
mmtiddy Jan. 21 at 11:13 AM
$TCBP Dude couldn’t defend his stock, let alone himself
1 · Reply
LovleyPeaches
LovleyPeaches Jan. 15 at 5:01 PM
$TCBP bryan kholberg nerds to be prosecuted
1 · Reply
Blackdog111
Blackdog111 Jan. 1 at 1:05 PM
$TCBP BRYON KOBEL TELLS MORE LIES THAN ANDREW MOUNTBATTON WINDSOR ITS
0 · Reply
Latest News on TCBP
No data available.
Kevin4540
Kevin4540 Feb. 23 at 6:15 PM
$TCBP
0 · Reply
ABnb15
ABnb15 Feb. 20 at 4:55 PM
$TCBP why this going up ??
0 · Reply
mldio
mldio Feb. 18 at 1:08 AM
$TCBP According to the annual report released in May 2025, over $40 million of shareholder capital was invested solely into IP research. Yet, in November 2025, this core asset was sold to CytoMed Therapeutics at a staggering "fire-sale" price. ​CytoMed, a micro-cap company with a market cap of only about $10 million, stated that the acquisition price was so "immaterial" to their operations that they chose to keep it undisclosed. If an acquisition is "immaterial" to a $10M company, at what absurdly low price did TCBP throw away an IP that cost shareholders $40M to develop? ​The deception goes deeper: ​June 2025: TCBP had already hired a bankruptcy firm to prepare for liquidation. ​August 2025: At the General Meeting, they pushed through value-destroying 'Deferred Shares'. ​The Lie: They told us these shares were to "flexibly raise capital to remain a going concern."that's totally BS.
0 · Reply
mldio
mldio Feb. 15 at 2:09 PM
$TCBP Under a YouTube video where Kobel gets totally knocked down, someone commented this: Apparently the CEO is a regular at a restaurant his wife runs, and he even brings that so-called “service dog” there and talks down to the staff the whole time. They say he’s pretty infamous in that area. This is who he really is.
0 · Reply
Blastus
Blastus Feb. 5 at 9:22 PM
$TCBP after a long time away, i came back to see Brian got punched in the face. Good. Dude is a sleezeball if I've ever seen one.
0 · Reply
RavsCan
RavsCan Feb. 2 at 2:41 PM
$TCBP old investor here. its a scam. dont even look in this direction. i’ve lost a ton. dont want others to follow. PLEASE LOOK AWAY.
0 · Reply
chris_stocks
chris_stocks Jan. 26 at 2:56 PM
$TCBP I hope Brian kobel dies very painfully
0 · Reply
mmtiddy
mmtiddy Jan. 21 at 11:13 AM
$TCBP Dude couldn’t defend his stock, let alone himself
1 · Reply
LovleyPeaches
LovleyPeaches Jan. 15 at 5:01 PM
$TCBP bryan kholberg nerds to be prosecuted
1 · Reply
Blackdog111
Blackdog111 Jan. 1 at 1:05 PM
$TCBP BRYON KOBEL TELLS MORE LIES THAN ANDREW MOUNTBATTON WINDSOR ITS
0 · Reply
Kevin4540
Kevin4540 Dec. 29 at 5:40 PM
$TCBP are you people fools this is a scam
1 · Reply
TheRealBearKillaAlerts
TheRealBearKillaAlerts Dec. 11 at 1:47 PM
$TCBP bullish reversal! This is the one! 🚀
1 · Reply
JVogel90
JVogel90 Dec. 10 at 9:18 PM
$TCBP There has to be grounds here for a class action lawsuit again Kobel.
0 · Reply
Kevin4540
Kevin4540 Dec. 1 at 5:50 PM
$TCBP this is the biggest piece of garbage anyone could ever possibly buy
0 · Reply
mldio
mldio Nov. 29 at 8:47 AM
$TCBP The company’s CEO claimed that he bought company stock around November 2024. But the 2023 and 2024 year-end reports show exactly the same thing — his common-share holdings didn’t change by even a single share. Unless he bought shares in November 2024 and immediately sold every last one of them, then in my view, his statement was absolutely not truthful. When I confronted him about this a few months ago, he said, “No. I did buy shares. My common-share count did change.” Hearing that made my blood boil — the answer felt completely dismissive and impossible to accept. he absolutely deserves to face consequences for his numerous lies.
3 · Reply
mldio
mldio Nov. 20 at 4:02 PM
$TCBP 3. Implementing a deferred share structure—one that effectively strips ordinary shareholders of their rights—is not unlawful by itself. However, in this case, it appears obvious that the company adopted it with liquidation in mind and with the intention of depriving existing ordinary shareholders of their liquidation rights. I believe this constitutes a form of deception toward shareholders. Including the matter above, I submitted eight allegations to the SEC and consulted several whistleblower-specialized law firms, but all declined representation. It is possible that what I believed to be violations were in fact not violations, or that the firms viewed the case as lacking sufficient appeal.
1 · Reply
mldio
mldio Nov. 20 at 4:02 PM
$TCBP I am not sure whether this kind of situation is common, and I would appreciate it if you could also look into it. 1. The company recently adopted a deferred share structure. As a result, the rights of existing ordinary shareholders were reduced to almost nothing, and they effectively lost any ability to claim residual assets in the event of liquidation. 2. At the time the company introduced the deferred share structure, it stated that the purpose was to enable more flexible share issuance under the restrictions of UK company law. However, as you know, the company entered administration less than a month after adopting this structure and ultimately proceeded to liquidation. This clearly shows that the adoption of deferred shares was inconsistent with the stated purpose of facilitating new share issuance.
0 · Reply
JVogel90
JVogel90 Nov. 19 at 4:25 PM
$TCBP As a public company with fiduciary duty to shareholders, how is this human piece of trash Kobel just allowed to sell off the assets to another company, then file to deregister the ADS shares here without compensating exisiting shareholders. This has got to be grounds for a class action lawsuit. This pos has screwed over investors for years.
1 · Reply
JVogel90
JVogel90 Nov. 19 at 5:35 AM
$TCBP https://www.investing.com/news/company-news/cytomed-acquires-tc-biopharms-gamma-delta-t-cell-technology-93CH-4365068 So another compant aquired their tcell science, and they are going to deregister the american dep shares. Are they not required by some type of law to compensate all the shareholders here that have not only been screwed over for years, but now permanenlty?!? How is this legal? Can we get a lawsuit going against this pos Kobel rat?
1 · Reply
WBReed
WBReed Nov. 17 at 3:10 PM
Today $TCBP has filed for insolvency.
2 · Reply
Mrious
Mrious Nov. 11 at 10:37 PM
$TCBP Does anyone know if there is a lawsuit against these crooks? If not, who else is ready to file one?
2 · Reply
Coastalcool
Coastalcool Nov. 3 at 3:55 PM
$TCBP Not an endorsement, but important Time line is approaching for (MRD) the cohort B of Achieve UK. Look out for the followings on November15th: 1. Complete Response/s persists . 2. Continued Recruitment ( more than 3 patients) If Both are affirmative , then Give the control of the Company to its original Founders . Only then this Company may have a chance.
4 · Reply